John J. Boniface, Chief Scientific Officer at SERA PROGNOSTICS, INC. (SERA), sold 2,044 shares at $4.16 ($9K) on 2025-03-06, disclosed to the SEC on 2025-03-07.
Seasonal sale ($9k) by Chief Scientific Officer — this insider has traded SERA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| SERA | SELL | 2025-12-11 | $4K | — | Filing → |
| SERA | SELL | 2025-11-12 | $20K | — | Filing → |
| SERA | SELL | 2025-09-12 | $4K | — | Filing → |